Changsatja S, Kositamongkol C, Thamlikitkul L, Phisalprapa P, Komonpaisarn T. COST-EFFECTIVENESS ANALYSIS OF ADJUVANT OSIMERTINIB IN RESECTED EGFR-MUTATED EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THAILAND. ICOPH [Internet]. 2025Jan.23 [cited 2025Jan.31];9(1):45-67. Available from: http://tiikmpublishing.com/proceedings/index.php/icoph/article/view/1543